政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/31347
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 113311/144292 (79%)
造访人次 : 50933374      在线人数 : 996
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/31347


    题名: 研究全球藥界併購趨勢及其影響力：以拜耳先靈西藥部為例
    A study of M&A trends and effects on global pharmaceutical industry: using bayer schering pharma as a model
    作者: 林芮珊
    Lin, Sandy
    贡献者: 吳文傑
    Wu, Jack
    林芮珊
    Lin, Sandy
    关键词: 併購
    日期: 2008
    上传时间: 2009-09-14 09:50:21 (UTC+8)
    摘要: 研究全球藥界併購趨勢及其影響力：以拜耳先靈西藥部為例
    Abstract

    A Study of M&A Trends and Effects on Global Pharmaceutical Industry: Using Bayer Schering Pharma as a Model
    By
    Sandy, Jui-San Lin
    The driving force for me to conduct a case writing related to M&A trends and effects in pharmaceutical industry as my master thesis is because I have been working with a global pharmaceutical subsidiary in Taipei whereby the company had experienced a series of post merger integrations. I was surprised by my research as 3 out of the 9 largest worldwide M&A transactions in 2000s were associated with pharmaceutics. The data is even more shocking as the total M&A value in pharmaceutical industry had contributed to almost 14% of the top transactions from 1990s to present (Table 1.2 & 1.3). I hope by going through the process, I will be able to learn more about the industry as what are the underlying factors and key considerations behind these mergers, how do those consolidated companies benefit from the action and where is the future? In my dissertation, I will first define what M&A action is as in general; present an overview on the global pharmaceutical world as what are the recent developments of M&A activities. Then I will concentrate on Bayer Healthcare and study its integration process with German Schering.
    1 Introduction………………………………………….…………..….1
    1.1 Defining M&A……………………………….…………..……1
    1.2 Synergies…..………………………………….………..……...3
    1.3 The Big Waves in M&A...…………………….………..……..4

    2 History of Pharma Industry.…………………………………….…12

    3 Market Analysis on Pharma Business.………………………….…16
    3.1 PEST(Political, Economic, Social and Technological)………16
    3.2 Porter Five Forces……………………………………………19

    4 Direction in Pharmaceutics Merges.…………………………….…22
    4.1 Vertical Waves in 1990s...…………………………………….22
    4.2 Horizontal Waves from Early 2000s………………………….25
    Case I Pfizer…………………………………………………..26
    Case II GSK…………………………………………………..30

    5 Background of the Main Case.……….………………………….…35
    5.1 History of Bayer...…………………………………………….35
    5.2 History of Schering AG……………………………………….40

    6 “The merge” for two becoming one….………………………….…42
    6.1 The forming of Bayer Schering Pharma…….………………..45
    6.2 Local Integration…………………………….………………..48

    7 Conclusion …………………………………………………………57


    References …………………………………………………………......59
    參考文獻: 1. Patrick A. Gaughan, Mergers (2002), Acquisitions and Corporate Restructuring 3rd Edition: Wiley M&A Library, p.23-55
    2. Jemison, D. B. & Sitkin, S.B. (1986), Corporate Acquisitions, A process perspective: Academy of Management Review, 11, p.145-163
    3. Judelson, D. N. (1969) The Conglomerate – Corporate Form of the Future: Harvard Business Review p.8-12
    4. Harold Geneen (1984), Managing: Doubleday
    5. Goold, M., & Quinn, J. B. (1990) Strategic Control: Hutchinson & Economist Publication
    6. Jensen, M. C. (1989), The Eclipse of Public Corporation: Harvard Business Review p.61-74
    7. Goold, M., & Luchs, K. (1993) Why Diversify? Four Decades of Management Thinking: Academy of Management Thinking 7(3), p.7-25
    8. Sikora, M. (1995), The Winding Trail: A 30 Years M&A Profile Dynamism: Mergers & Acquisitions p.45-50
    9. Shleifer, A., & Vishny R. W. (1994), Takeovers in the 1960s & 1980s: Evidence & Implications: Harvard Business School Press
    10. Sikora, M. (1997), Why the M&A Boom Isn’t Dying Down: Mergers & Acquisitions p.5-7
    11. Watson, R. Jr. (2000), What to Do Merge, Diversify What to Do Expand and Liquidate: The Cornell Hotel & Administration Quarterly, 1: p.14-21
    12. Institute of Mergers, Acquisitions and Alliances (MANDA): http://www.imaa-institute.org/en/index.php
    13. Med Ad News: http://www.pharmalive.com/magazines/medad/?date=09%2F2007
    14. PBM Highlights: http://www.okcu.edu/economics/ASSIGN/JWILLNER/5203/Articles/DrugsCompaniesMergerDeMerger.pdf
    15. Oligopoly Watch: http://www.badfaithinsurance.org/reference/GMCOPBM/0011a.htm
    16. http:www.contractpharma.com
    17. Stephen P. Bradley, Matthew Sandoval (2000), The Drug Wars: Pfizer’s Hostile Bid for Warner-Lamber in 1999: Harvard Business Review
    18. Pfizer Website: http://www.pfizer.com/home/
    19. GSK Website: http://www.gsk.com
    20. Bayer Website: http://www.bayer.com
    21. Bayer Schering Pharma Website: http://www.bayerscheringpharma.de/scripts/pages/de/index.php
    22. http://www.investopedia.com/university/mergers/mergers1.asp
    23. http://www.wikipedia.com
    24. http://www.answers.com
    描述: 碩士
    國立政治大學
    國際經營管理碩士班(IMBA)
    95933022
    97
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0095933022
    数据类型: thesis
    显示于类别:[國際經營管理英語碩士學程IMBA] 學位論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML2346检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈